The/DT
NF-kappa/NN
B/NN
inhibitor/NN
,/,
tepoxalin/NN
,/,
suppresses/VBZ
surface/NN
expression/NN
of/IN
the/DT
cell/NN
adhesion/NN
molecules/NNS
CD62E/NN
,/,
CD11b/CD18/NN
and/CC
CD106/NN
./.

Tepoxalin/NN
,/,
a/DT
dual/JJ
enzyme/NN
inhibitor/NN
of/IN
cyclooxygenase/NN
and/CC
5-lipoxygenase/NN
has/VBZ
been/VBN
shown/VBN
to/TO
inhibit/VB
T-cell/NN
activation/NN
./.
=====
Its/PRP$
immunosuppressive/JJ
property/NN
is/VBZ
distinct/JJ
from/IN
cyclosporin/NN
because/IN
only/RB
tepoxalin/NN
,/,
but/CC
not/RB
cyclosporin/NN
,/,
suppresses/VBZ
NF-kappa/NN
B/NN
activation/NN
./.
=====
Here/RB
we/PRP
report/VBP
that/IN
tepoxalin/NN
selectively/RB
inhibits/VBZ
intercellular/JJ
adhesion/NN
molecule-1/NN
(/(
ICAM-1/NN
,/,
CD54/NN
)/)
/MAC-1/NN
(/(
CD11b/CD18/NN
)/)
dependent/JJ
adhesion/NN
of/IN
polymorphonuclear/JJ
cells/NNS
to/TO
IL-1/NN
activated/JJ
human/JJ
umbilical/JJ
vein/NN
endothelial/JJ
cells/NNS
./.
=====
The/DT
mechanism/NN
of/IN
inhibition/NN
is/VBZ
related/JJ
to/TO
the/DT
surface/NN
expression/NN
of/IN
several/JJ
cell/NN
adhesion/NN
molecules/NNS
./.
=====
Flow/NN
cytometry/NN
analyses/NNS
on/IN
cultured/VBN
cells/NNS
that/WDT
were/VBD
treated/VBN
with/IN
tepoxalin/NN
or/CC
antisense/JJ
oligonucleotides/NNS
to/TO
the/DT
P65/p50/NN
subunit/NN
of/IN
NF-kappa/NN
B/NN
,/,
and/CC
then/RB
stimulated/VBN
with/IN
PMA/NN
,/,
revealed/VBD
a/DT
reduced/VBN
expression/NN
of/IN
CD11b/CD18/NN
on/IN
monocytic/JJ
HL60/NN
cells/NNS
,/,
and/CC
endothelial/JJ
adhesion/NN
molecule-1/NN
(/(
CD62E/NN
)/)
and/CC
vascular/JJ
adhesion/NN
molecule-1/NN
(/(
CD106/NN
)/)
on/IN
human/JJ
umbilical/JJ
vein/NN
endothelial/JJ
cells/NNS
./.
=====
Expression/NN
of/IN
other/JJ
adhesion/NN
molecules/NNS
such/JJ
as/IN
lymphocyte/NN
function/NN
associated-antigen-1/NN
(/(
CD11a/CD18/NN
)/)
and/CC
CD54/NN
were/VBD
unaffected/JJ
./.
=====
Tepoxalin/NN
also/RB
inhibited/VBD
the/DT
secretion/NN
of/IN
a/DT
NF-kappa/NN
B/NN
regulated/JJ
chemokine/NN
,/,
IL-8/NN
,/,
a/DT
known/JJ
inducer/NN
of/IN
CD11b/CD18/NN
expression/NN
./.
=====
Thus/RB
the/DT
suppression/NN
of/IN
CD11b/CD18/NN
expression/NN
by/IN
tepoxalin/NN
may/MD
involve/VB
IL-8/NN
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
by/IN
inhibiting/VBG
NF-kappa/NN
B/NN
activation/NN
,/,
surface/NN
expression/NN
of/IN
several/JJ
adhesion/NN
molecules/NNS
can/MD
be/VB
modulated/VBN
and/CC
that/IN
tepoxalin/NN
may/MD
be/VB
useful/JJ
in/IN
treating/VBG
selected/VBN
adhesion/NN
mediated/JJ
events/NNS
such/JJ
as/IN
leukocyte/NN
migration/NN
or/CC
atherosclerotic/JJ
plaque/NN
formation/NN
./.